Orgovyx 120 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P3D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,920
Award facts
- Contract value 100% obligated
- $2,920.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 6, 2026, for the supply of ORGOVYX 120 MG tablets in quantities of 30 units, with a contract ceiling value of $2,920.26. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 28, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to federal medical supply chains, particularly supporting military and veteran healthcare systems. The parent company, Cencora, Inc., also maintains a separate significant IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, reflecting the company's substantial role as a critical vendor for federal pharmaceutical procurement. The delivery of ORGOVYX, a specialty pharmaceutical product, exemplifies the company's capability to fulfill federal medical supply requirements through open competition and efficient order fulfillment mechanisms.
Quick answers
Who was awarded contract SPE2DR26F3P3D?
SPE2DR26F3P3D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F3P3D worth?
The government has obligated $2,920 on SPE2DR26F3P3D.
Is contract SPE2DR26F3P3D an order under another contract?
Yes. SPE2DR26F3P3D is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P3D competed?
The extent of competition for SPE2DR26F3P3D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award